Toolkit/MS2 virus-like particles
MS2 virus-like particles
Also known as: MS2 phage coat protein VLPs, MS2 VLPs
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
The coat protein of the MS2 self-assembles into virus-like particles (VLPs) with a diameter of 26 nm. These VLPs are devoid of the phage genome yet are efficiently recognized by the immune system, eliciting robust humoral and cellular immune responses. The structural characteristics of VLPs position them as a promising platform for the development of vaccines and diagnostic tools.
Usefulness & Problems
No literature-backed usefulness or problem-fit explainer has been materialized for this record yet.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A delivery strategy grouped with the mechanism branch because it determines how a system is instantiated and deployed in context.
Techniques
Structural CharacterizationTarget processes
diagnosticValidation
Supporting Sources
Ranked Claims
MS2 phage coat protein VLPs are reviewed as a versatile platform with applications in viral, parasite, chlamydial, and cancer immunotherapy.
Antigenic peptides up to 91 amino acids can be densely displayed at the N-terminal beta-hairpin AB loop of the MS2 coat protein through genetic engineering.
Fusion of an exogenous sequence with the 19-nucleotide pac site enables selective incorporation of heterologous RNA into MS2 VLPs.
Genome-free MS2 VLPs are efficiently recognized by the immune system and elicit robust humoral and cellular immune responses.
MS2 coat protein self-assembles into approximately 26 nm virus-like particles.
Approval Evidence
The coat protein of the MS2 self-assembles into virus-like particles (VLPs) with a diameter of 26 nm. These VLPs are devoid of the phage genome yet are efficiently recognized by the immune system, eliciting robust humoral and cellular immune responses. The structural characteristics of VLPs position them as a promising platform for the development of vaccines and diagnostic tools.
Source:
MS2 phage coat protein VLPs are reviewed as a versatile platform with applications in viral, parasite, chlamydial, and cancer immunotherapy.
Source:
Fusion of an exogenous sequence with the 19-nucleotide pac site enables selective incorporation of heterologous RNA into MS2 VLPs.
Source:
Genome-free MS2 VLPs are efficiently recognized by the immune system and elicit robust humoral and cellular immune responses.
Source:
MS2 coat protein self-assembles into approximately 26 nm virus-like particles.
Source:
Comparisons
No literature-backed comparison notes have been materialized for this record yet.
Ranked Citations
- 1.